483 Novitium Pharma Feb 2019

483 Novitium Pharma Feb 2019

Frederick Razzaghi FDA$119.00 - Available Now

FDA investigators audited the Novitium Pharma - East Windsor, NJ, United States facility and issued inspectional observations (via FDA 483) on 04 Feb 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 04 Feb 2019
  • Location: East Windsor, United States
  • FEI: 3012541241
Add To Cart